CIK 0001439725 · Non-accelerated filer<br>Smaller reporting company
BIODESIX INC
Sign in to watch- Ticker
- BDSX
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203986492
- Phone
- 303-417-0500
- Business address
- 919 WEST DILLON ROAD, LOUISVILLE, CO, 80027
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Material agreement · Unregistered share sale · Bylaws or fiscal year change · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 4 Option exercise Director acquired 134,262 shares (option exercise)
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Accounting Officer sold 1,999 shares at an average $1.80 ($3,599)
- 4 Open-market sale Chief Development Officer sold 10,884 shares at an average $1.80 ($19,595)
- 4 Open-market sale Chief Commercial Officer sold 11,731 shares at an average $1.80 ($21,120)
- 4 Open-market sale President & CEO sold 64,390 shares at an average $1.80 ($115,926)
- 4 Open-market sale CFO, Sec'y & Treasurer sold 18,855 shares at an average $1.80 ($33,946)
Page 12 of 31 · 602 filings